Baidu
map

Diabetes Care :手术患者他汀治疗增加胰岛素抵抗

2012-07-31 邓涛 医学论坛网

  外伤手术胰岛素敏感性与术后不良反应相关,近期术前他汀治疗被推荐用于冠状动脉疾病患者,而同时有报道称他汀治疗能够增加胰岛素抵抗和新发糖尿病风险。7月24日在线刊登于《糖尿病护理》杂志上一项分析显示,接受冠状动脉旁路移植术的非糖尿病血脂异常患者,术前使用他汀治疗增加非糖尿病高血脂患者胰岛素抵抗。   该研究为前瞻性非随机研究,共纳入120例患者,分为他汀组(接受亲脂性他汀治疗患者)和对照组(

  外伤手术胰岛素敏感性与术后不良反应相关,近期术前他汀治疗被推荐用于冠状动脉疾病患者,而同时有报道称他汀治疗能够增加胰岛素抵抗和新发糖尿病风险。7月24日在线刊登于《糖尿病护理》杂志上一项分析显示,接受冠状动脉旁路移植术的非糖尿病血脂异常患者,术前使用他汀治疗增加非糖尿病高血脂患者胰岛素抵抗。

  该研究为前瞻性非随机研究,共纳入120例患者,分为他汀组(接受亲脂性他汀治疗患者)和对照组(未接受任何他汀治疗的高血脂患者)。术中采用高胰岛素浓度-正糖钳夹技术评估胰岛素敏感性,计算所有患者术后的平均血糖SD和变异系数(CV),采用多元回归分析评估他汀治疗与术中胰岛素敏感性的关系。

  研究结果显示,术中2组胰岛素敏感性均逐渐下降,与对照组相比,他汀组平均胰岛素敏感性低20%,他汀组重症监护病房患者的血糖则更高[(153±20)mg/dl对(140± 20)mg/dl;P<0.001],血糖波动更明显。多元回归分析结果表明,他汀治疗与术中胰岛素敏感性独立相关。
 
链接:

Sato H,Carvalho G,Sato T,Hatzakorzian R,Lattermann R,Codere-Maruyama T,Matsukawa T,Schricker T.Statin Intake Is Associated With Decreased Insulin Sensitivity During Cardiac Surgery.Diabetes Care 2012 Jul 24

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1749359, encodeId=c1a51e4935910, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Fri Mar 15 06:46:00 CST 2013, time=2013-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636532, encodeId=2ffb163653262, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Jun 01 16:46:00 CST 2013, time=2013-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759164, encodeId=12ed1e5916482, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Mar 24 10:46:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900973, encodeId=e7ae19009e361, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri May 10 16:46:00 CST 2013, time=2013-05-10, status=1, ipAttribution=)]
    2013-03-15 baoya
  2. [GetPortalCommentsPageByObjectIdResponse(id=1749359, encodeId=c1a51e4935910, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Fri Mar 15 06:46:00 CST 2013, time=2013-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636532, encodeId=2ffb163653262, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Jun 01 16:46:00 CST 2013, time=2013-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759164, encodeId=12ed1e5916482, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Mar 24 10:46:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900973, encodeId=e7ae19009e361, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri May 10 16:46:00 CST 2013, time=2013-05-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1749359, encodeId=c1a51e4935910, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Fri Mar 15 06:46:00 CST 2013, time=2013-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636532, encodeId=2ffb163653262, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Jun 01 16:46:00 CST 2013, time=2013-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759164, encodeId=12ed1e5916482, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Mar 24 10:46:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900973, encodeId=e7ae19009e361, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri May 10 16:46:00 CST 2013, time=2013-05-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1749359, encodeId=c1a51e4935910, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Fri Mar 15 06:46:00 CST 2013, time=2013-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636532, encodeId=2ffb163653262, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Jun 01 16:46:00 CST 2013, time=2013-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759164, encodeId=12ed1e5916482, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Mar 24 10:46:00 CST 2013, time=2013-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900973, encodeId=e7ae19009e361, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri May 10 16:46:00 CST 2013, time=2013-05-10, status=1, ipAttribution=)]

相关资讯

Stroke:停用他汀类药物影响颅内出血转归

       3月22日,《卒中》(Stroke)杂志在线发表的加拿大的一项研究显示:入院前他汀类药物的使用和颅内出血的转归没有关联;停用他汀类药物可能使转归恶化,或可能仅仅是预后较差的一个潜在标志。   研究人员根据加拿大卒中协作网的登记数据,对2003~2008年连续登记的2466例颅内出血病人(平均年龄为71岁;53.6%为男性)进行了分析。

FDA修改了他汀类药物安全信息

 2012年2月28日,美国食品与药物管理局(FDA)批准了对他汀类标签安全信息的重要修改。   修改内容包括:   1、新修订的药物标签,取消了常规定期监测用药者肝酶的要求。推荐患者在接受他汀药物治疗前,以及随后根据临床指征,进行肝酶检测。FDA已得出结论:个别患者服用他汀类药物所致的严重肝损伤,少见且不可预知,常规周期性监测肝酶水平,似乎不能有效发现或预防严重肝损伤。服用该类药物的患者,

停用他汀的类风湿关节炎患者 心血管死亡风险增加60%

 加拿大和美国一项联合研究显示,对于接受他汀类药物治疗的类风湿关节炎(RA)患者,停用他汀可使其心血管疾病(CVD)和全因死亡风险分别增加60%和79%。RA患者应认识到依从于他汀治疗的重要性。论文3月28日在线发表于《关节炎护理和研究》(Arthritis Care Res)杂志。

他汀调脂,无可替代的一线用药

  本期辩题:“从临床效应看,他汀是否是唯一可改善血脂异常与心血管高危患者远期预后的药物,贝特和烟酸类药物是否拥有一席之地?”   血脂异常是一个复杂的概念,包括总胆固醇升高、低密度脂蛋白胆固醇(LDL-C)升高、甘油三酯(TG)升高以及高密度脂蛋白胆固醇(HDL-C)降低等表现。大量流行病学研究数据证实,LDL-C升高与动脉粥样硬化性心血管疾病间存在密切关系,数十项大型随机临床试验充分肯定了应

2012 AAN年会:他汀类或降低卒中早期死亡率

    2012年4月21-28日,第64届美国神经病学会年会在美国新奥尔良召开。会上,研究者报告,卒中前使用他汀类药物的卒中患者死亡风险显著低于未使用胆固醇调节药物的患者。       德国吕贝克大学的Mohamed Al-Khaled博士说,因高胆固醇血症接受他汀类药物治疗患者早期死亡率为2.1%,而未接受他汀类治

Arch Neuro:他汀类药物可明显降低帕金森病的发病风险

近日,国际著名杂志《神经病学文献》Archive of Neurology在线刊登饿了哈佛大学公共卫生学院营养学系研究人员的最新研究成果,文章中,研究者Xiang Gao博士表示,对2项仍在进行中的大规模研究的前瞻性观察性分析显示,规律服用他汀类药物的患者发生帕金森病的风险“临界显著性” 降低。与老年人相比,他汀类对60岁以下人群的保护作用更加明显。 他汀类药物具有较强的抗炎和免疫调节作用,

Baidu
map
Baidu
map
Baidu
map